关注
Panayiotis Vlachoyiannopoulos
Panayiotis Vlachoyiannopoulos
National and Kapodistrian University of Athens, Professor of Medicine-Immunology
在 med.uoa.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis, MD Lockshin, T Atsumi, DW Branch, RL Brey, R Cervera, ...
Journal of thrombosis and haemostasis 4 (2), 295-306, 2006
84542006
Mortality in systemic sclerosis: an international meta-analysis of individual patient data
JPA Ioannidis, PG Vlachoyiannopoulos, AB Haidich, TA Medsger Jr, ...
The American journal of medicine 118 (1), 2-10, 2005
5792005
Mapping and predicting mortality from systemic sclerosis
M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ...
Annals of the rheumatic diseases 76 (11), 1897-1905, 2017
5582017
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ...
The Lancet Respiratory Medicine 8 (10), 963-974, 2020
4832020
Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual
J Nossent, N Cikes, E Kiss, A Marchesoni, V Nassonova, M Mosca, ...
Lupus 16 (5), 309-317, 2007
3272007
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long‐term outcome
MG Tektonidou, F Sotsiou, L Nakopoulou, PG Vlachoyiannopoulos, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2004
3012004
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
I Pakas, JPA Ioannidis, K Malagari, FN Skopouli, HM Moutsopoulos, ...
The Journal of rheumatology 29 (2), 298-304, 2002
2162002
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
PG Vlachoyiannopoulos, E Magira, H Alexopoulos, E Jahaj, ...
Annals of the Rheumatic Diseases 79 (12), 1661-1663, 2020
2132020
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria
G Valentini, W Bencivelli, S Bombardieri, S D’Angelo, A Della Rossa, ...
Annals of the rheumatic diseases 62 (9), 901-903, 2003
2092003
Subgroups of Sjögren syndrome patients according to serological profiles
VK Bournia, PG Vlachoyiannopoulos
Journal of autoimmunity 39 (1-2), 15-26, 2012
2052012
Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases
MG Tektonidou, M Anapliotou, P Vlachoyiannopoulos, HM Moutsopoulos
Annals of the rheumatic diseases 63 (9), 1159-1161, 2004
2002004
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus
J Nossent, E Kiss, B Rozman, G Pokorny, P Vlachoyiannopoulos, ...
Lupus 19 (8), 949-956, 2010
1952010
Digital ulcers predict a worse disease course in patients with systemic sclerosis
C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ...
Annals of the rheumatic diseases 75 (4), 681-686, 2016
1812016
Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study
M Cutolo, AL Herrick, O Distler, MO Becker, E Beltran, P Carpentier, ...
Arthritis & rheumatology 68 (10), 2527-2539, 2016
1672016
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
J Avouac, UA Walker, E Hachulla, G Riemekasten, G Cuomo, PE Carreira, ...
Annals of the rheumatic diseases 75 (1), 103-109, 2016
1572016
Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging
MG Tektonidou, K Malagari, PG Vlachoyiannopoulos, DA Kelekis, ...
Arthritis & Rheumatism 48 (3), 732-736, 2003
1562003
Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study
PG Vlachoyiannopoulos, PG Kanellopoulos, JPA Ioannidis, ...
Rheumatology 42 (5), 645-651, 2003
1532003
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres
A Della Rossa, G Valentini, S Bombardieri, W Bencivelli, AJ Silman, ...
Annals of the rheumatic diseases 60 (6), 585-591, 2001
1532001
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation
AJG Swaak, HG van Den Brink, RJT Smeenk, K Manger, JR Kalden, ...
Rheumatology 38 (10), 953-958, 1999
1511999
Treatment of rheumatoid arthritis: unraveling the conundrum
E Zampeli, PG Vlachoyiannopoulos, AG Tzioufas
Journal of autoimmunity 65, 1-18, 2015
1482015
系统目前无法执行此操作,请稍后再试。
文章 1–20